Methicillin-Resistant Staphylococcus Aureus Treatment Market Share and Top Players

The major players in the methicillin-resistant staphylococcus aureus (MRSA) treatment market include Pfizer, Inc., Allergan Plc, Johnsons & Johnson, Merck & Co., Inc., Novartis AG, Baxter Healthcare Corporation, Fresenius Kabi LLC, Bausch Health Companies Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy’s Laboratories Ltd., Akron Pharma Inc., Mayne Pharma Group Limited, Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Debiopharm International SA, Herbal Intervention, LLC, Bio-Germ Protection LLC.

Increasing private and government investments in R &D to develop novel antibiotics against MRSA infections and raising awareness about the MRSA infection is further supporting the market. During the COVID-19 pandemic, the global MRSA treatment market is likely to expand as a large population taking treatment in the hospital due to COVID-19, and the possibilities of healthcare-acquired MRSA infection are high.

The entire methicillin-resistant staphylococcus aureus (MRSA) treatment market has been sub-categorized into drug class, route of administration, distribution channel , indication and types of MRSA.

By Drug Class

  • Glycopeptides
  • Lipopeptides
  • Oxazolidinones
  • Glycylcycline
  • Streptogramins
  • Lincomycin
  • Tetracycline
  • Lipoglycopeptides
  • Antiseptics
  • Naturals/Herbals
  • Others

By Route of Administration

  • Intravenous
  • Oral
  • Topical
  • Nasal
  • Cutaneous
  • Intramuscular

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drugstores
  • Online Pharmacies

By Indication

  • Skin and Soft Tissue Infections (SSTIs)
  • Pneumonia
  • Bloodstream Infections
  • Surgical and Medical Infections
  • Others

By Types of MRSA

  • Healthcare Acquired MRSA
  • Community Acquired MRSA
  • Hospital Acquired MRSA

demand for methicillin-resistant staphylococcus aureus (MRSA) treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Source: https://www.valuemarketresearch.com/report/methicillin-resistant-staphylococcus-aureus-mrsa-treatment-market

Leave a Reply

Your email address will not be published. Required fields are marked *

Social Media Auto Publish Powered By : XYZScripts.com